IL1B and Parkinson disease: Based on these findings, it is conceivable that, in the very early stages of PD, before CNS pathology, enteric α-syn accumulation promotes the activation of immune/inflammatory signaling, including canonical inflammasome pathways, with massive release of IL-1β, and subsequent impairment of IEB integrity and changes in gut microbiota metabolite production.